Total Payments
$150.62
2024 Payments
$65.46
Companies
5
Transactions
9
Medicare Patients
2,254
Medicare Billing
$166,705
Payment Breakdown by Category
Food & Beverage$121.70 (80.8%)
Education$28.92 (19.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $121.70 | 7 | 80.8% |
| Education | $28.92 | 2 | 19.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mylan Specialty L.P. | $65.46 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $40.72 | 3 | $0 (2017) |
| Sanofi Pasteur Inc. | $15.52 | 1 | $0 (2018) |
| PFIZER INC. | $15.03 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.89 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65.46 | 3 | Mylan Specialty L.P. ($65.46) |
| 2019 | $15.03 | 1 | PFIZER INC. ($15.03) |
| 2018 | $15.52 | 1 | Sanofi Pasteur Inc. ($15.52) |
| 2017 | $54.61 | 4 | GlaxoSmithKline, LLC. ($40.72) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/05/2019 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $15.03 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/28/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), ADACEL, NO PRODUCT DISCUSSED | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: VACCINES | ||||||
| 10/13/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: RESPIRATORY | ||||||
| 06/01/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: RESPIRATORY | ||||||
| 05/04/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 01/18/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 576 | 909 | $110,530 | $42,561 |
| 2022 | 11 | 517 | 979 | $121,760 | $41,202 |
| 2021 | 15 | 564 | 941 | $112,670 | $39,286 |
| 2020 | 11 | 597 | 1,101 | $138,525 | $43,656 |
Total Patients
2,254
Total Services
3,930
Medicare Billing
$166,705
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 177 | $52,215 | $18,399 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 75 | 75 | $20,250 | $10,637 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 98 | $18,130 | $6,996 | 38.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 49 | 97 | $8,730 | $1,910 | 21.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 109 | 213 | $3,195 | $1,789 | 56.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 85 | 85 | $4,250 | $1,775 | 41.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 39 | 69 | $1,035 | $421.59 | 40.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 39 | 69 | $1,035 | $350.52 | 33.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 26 | $1,690 | $282.48 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 265 | $78,175 | $25,142 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 68 | $12,580 | $5,031 | 40.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 20 | 20 | $5,400 | $2,923 | 54.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $3,700 | $2,602 | 70.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 53 | 91 | $8,190 | $1,689 | 20.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 12 | 25 | $3,750 | $1,188 | 31.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 122 | 314 | $4,710 | $929.79 | 19.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 35 | 35 | $1,750 | $733.95 | 41.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 36 | 61 | $915.00 | $375.05 | 41.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 35 | 60 | $900.00 | $306.70 | 34.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 25 | 26 | $1,690 | $282.64 | 16.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 107 | 227 | $66,965 | $21,418 | 32.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 30 | 30 | $8,150 | $5,632 | 69.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 25 | 25 | $6,750 | $3,720 | 55.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 57 | 103 | $9,270 | $1,818 | 19.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 23 | $4,255 | $1,565 | 36.8% |
About Dr. Laila Attar, M.D
Dr. Laila Attar, M.D is a Family Medicine healthcare provider based in Pepperell, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174589311.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laila Attar, M.D has received a total of $150.62 in payments from pharmaceutical and medical device companies, with $65.46 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($121.70).
As a Medicare-enrolled provider, Attar has provided services to 2,254 Medicare beneficiaries, totaling 3,930 services with total Medicare billing of $166,705. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Pepperell, MA
- Active Since 04/25/2006
- Last Updated 01/21/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174589311
Products in Payments
- YUPELRI (Drug) $65.46
- ANORO (Drug) $40.72
- FLUZONE HIGH-DOSE (Drug) $15.52
- CHANTIX (Drug) $15.03
- STIOLTO (Drug) $13.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.